Resmed (RSMDF) Cash from Operations (2009 - 2026)

Resmed has reported Cash from Operations for 18 years, with the latest figure at 554132000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 4.24% year-over-year to 554132000.0; the trailing twelve-month figure through Mar 2026 stood at 1889964000.0 (up 14.34% YoY), and the FY2025 full-year result was 1751588000.0, up 25.0% from the prior year.
• Cash from Operations for Q1 2026 stood at 554132000.0, up from 339745000.0 in the prior quarter.
• The five-year high for Cash from Operations was 578661000.0 in Q1 2025, with the low at 44662000.0 in Q3 2022.
• Historically, Cash from Operations has averaged 317310000.0 across 5 years, with a median of 308623000.0 in 2024.
• Annual changes were most pronounced in 2022 — Cash from Operations sank 64.91% — and 2023, when it surged 541.0%.
• Resmed's Cash from Operations stood at 128636000.0 in 2022, then surged by 112.1% to 272832000.0 in 2023, then advanced by 13.12% to 308623000.0 in 2024, then rose by 10.08% to 339745000.0 in 2025, then soared by 63.1% to 554132000.0 in 2026.
• The last three Cash from Operations figures came in at 554132000.0 (Q1 2026), 339745000.0 (Q4 2025), and 457321000.0 (Q3 2025), per Business Quant data.